{"entity":{"type":"insider","cik":"0001832019","url":"/insider/0001832019","json_url":"/insider/0001832019.json","name":"Transcend Partners Opportunity Fund LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2021-08-03","last":"2022-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Transcend Partners Opportunity Fund LLC","source":"filing","n_filings":2,"first_seen":"2021-08-03","last_seen":"2022-08-18"}],"transactions":[{"id":6212014,"accession":"0001209191-22-046616","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-046616","line_url":"/filing/0001209191-22-046616#line-1","is_derivative":false,"issuer_cik":"0001682638","issuer_name":"IN8BIO, INC.","issuer_ticker":"INAB","issuer_name_source":null,"issuer_url":"/issuer/0001682638","owner_cik":null,"owner_name":"Transcend Partners Opportunity Fund LLC; FAIRBAIRN EMILY","owner_display_name":"Transcend Partners Opportunity Fund LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":789473.0,"shares_display":"789,473","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":1499998.7,"total_display":"1,499,998.70","total_whole":"1,499,999","shares_owned_after":4111958.0,"shares_owned_after_display":"4,111,958","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":4731220,"accession":"0001209191-21-049368","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-049368","line_url":"/filing/0001209191-21-049368#line-4","is_derivative":false,"issuer_cik":"0001682638","issuer_name":"IN8BIO, INC.","issuer_ticker":"INAB","issuer_name_source":null,"issuer_url":"/issuer/0001682638","owner_cik":null,"owner_name":"FAIRBAIRN EMILY; Transcend Partners Opportunity Fund LLC","owner_display_name":"FAIRBAIRN EMILY","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":3322485.0,"shares_owned_after_display":"3,322,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001740279","name":"IN8BIO, INC.","url":"/issuer/0001740279","role":"Ten percent owner","n_filings":2,"first_seen":"2021-08-03","last_seen":"2022-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001832019","retrieved_at":"2026-08-25T18:02:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}